ANRO (Alto Neuroscience) Current Accrued Expense : $7.56 Mil (As of Dec. 2024)

View and export this data going back to 2024. Start your Free Trial

What is Alto Neuroscience Current Accrued Expense?

Alto Neuroscience's Current Accrued Expense for the quarter that ended in Dec. 2024 was $7.56 Mil.

Alto Neuroscience's quarterly Current Accrued Expense increased from Jun. 2024 ($5.68 Mil) to Sep. 2024 ($7.52 Mil) and increased from Sep. 2024 ($7.52 Mil) to Dec. 2024 ($7.56 Mil).

Alto Neuroscience's annual Current Accrued Expense increased from Dec. 2022 ($3.67 Mil) to Dec. 2023 ($4.41 Mil) and increased from Dec. 2023 ($4.41 Mil) to Dec. 2024 ($7.56 Mil).

Alto Neuroscience Current Accrued Expense Historical Data

The historical data trend for Alto Neuroscience's Current Accrued Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Alto Neuroscience Current Accrued Expense Chart

Alto Neuroscience Annual Data

Trend

Dec21

Dec22

Dec23

Dec24

Current Accrued Expense

1.21

3.67

4.41

7.56

Alto Neuroscience Quarterly Data
	Dec21	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24
Current Accrued Expense	Get a 7-Day Free Trial					4.41	4.39	5.68	7.52	7.56

Alto Neuroscience Current Accrued Expense Calculation

Current Accrued Expense is the expense incurred during the accounting period, but not required to be paid until a later date. It includes compensation, interest, pensions and all other miscellaneous accruals reported by the company.

Alto Neuroscience Current Accrued Expense Related Terms

Thank you for viewing the detailed overview of Alto Neuroscience's Current Accrued Expense provided by GuruFocus.com. Please click on the following links to see related term pages.

Alto Neuroscience Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Alto Neuroscience Inc (NYSE:ANRO) » Definitions » Current Accrued Expense

Comparable Companies

Traded in Other Exchanges

N/A

Address

650 Castro Street, Suite 450, Mountain View, CA, USA, 94041

Website

https://www.altoneuroscience.com

Alto Neuroscience Inc is a clinical-stage biopharmaceutical company with a mission to redefine psychiatry by leveraging individuals' neurobiology to develop personalized and effective treatment options. The company currently consists of different clinical-stage assets such as ALTO-100, ALTO-202, ALTO-101, and ALTO-300 among others initially targeting depressive disorders and schizophrenia populations as identified by independent brain-based biomarkers.